FindTrial
Sign In

Research on an optimized anti-hypertensive treatment in patients with renal dysfunction complicated with hypertension

Research on an optimized anti-hypertensive treatment in patients with renal dysfunction complicated with hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TQR-12002674
Enrollment
Unknown
Registered
2012-11-16
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension complicated with hypertension

Interventions

1:Amlodipine antihypertensive therapy
2:Amlodipine + Irbesartan
3:Amlodipine + Arotinolol
4:Amlodipine

Sponsors

Xiangya affiliated the 3rd hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 72 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 60 years old, hypertension

Exclusion criteria

Exclusion criteria: The onset of acute cardiovascular and cerebrovascular events, complicated with severe liver disease, severe cardiomyopathy, rheumatic heart disease, congenital heart disease, unstable angina, malignant tumors, gout, are taking contraceptives or pregnancy women on study drugclear history of allergic reactions to the study drug contraindications. Kidney transplantation, renal artery stenosis caused by hypertension.

Design outcomes

Primary

MeasureTime frame
Ambulatory blood pressure monitoring;blood concentrition of amlodipin;—

Countries

China

Contacts

Public ContactYuan Hong, Zhang Hao
yuanhong1975@163.com+86 0731 88618319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026